213 related articles for article (PubMed ID: 33760151)
1. miR‑320a‑3P alleviates the epithelial‑mesenchymal transition of A549 cells by activation of STAT3/SMAD3 signaling in a pulmonary fibrosis model.
Wang X; Wang J; Huang G; Li Y; Guo S
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760151
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.
Wang X; Gao JL; Zhao MM; Zhu HX; Tian YX; Li R; Jiang XH; Yu L; Tian JR; Cui JZ
Int J Mol Med; 2018 Feb; 41(2):659-668. PubMed ID: 29207055
[TBL] [Abstract][Full Text] [Related]
3. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide: A novel mediator for TGF-β1-induced epithelial-mesenchymal transition in 16HBE-14o and A549 cells.
Chu S; Zhang X; Sun Y; Yu Y; Liang Y; Jiang M; Huang J; Ma L
Peptides; 2017 Apr; 90():1-9. PubMed ID: 28229930
[TBL] [Abstract][Full Text] [Related]
5. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.
Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ
J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
Tan QY; Cheng ZS
Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
[TBL] [Abstract][Full Text] [Related]
7. Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition.
Lin L; Han Q; Xiong Y; Li T; Liu Z; Xu H; Wu Y; Wang N; Liu X
Sci Rep; 2017 Nov; 7(1):15847. PubMed ID: 29158503
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
9. Paraquat poisoning induced pulmonary epithelial mesenchymal transition through Notch1 pathway.
Li T; Yang X; Xin S; Cao Y; Wang N
Sci Rep; 2017 Apr; 7(1):924. PubMed ID: 28424456
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR‑483‑5p inhibits TGF‑β1‑induced EMT by targeting RhoGDI1 in pulmonary fibrosis.
Huang G; Zhang J; Qing G; Liu D; Wang X; Chen Y; Wu Y; Li Y; Guo S
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34080651
[TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
13. Expression of TRB3 promotes epithelial‑mesenchymal transition of MLE‑12 murine alveolar type II epithelial cells through the TGF‑β1/Smad3 signaling pathway.
Cheng W; Mi L; Tang J; Yu W
Mol Med Rep; 2019 Apr; 19(4):2869-2875. PubMed ID: 30720074
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
15. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
[TBL] [Abstract][Full Text] [Related]
16. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T
BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661
[TBL] [Abstract][Full Text] [Related]
17. Effect of long noncoding RNAs on epithelial-mesenchymal transition in A549 cells and fibrotic human lungs.
Yildirim M; Oztay F; Kayalar O; Tasci AE
J Cell Biochem; 2021 Aug; 122(8):882-896. PubMed ID: 33847014
[TBL] [Abstract][Full Text] [Related]
18. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
19. Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis.
Zou XZ; Gong ZC; Liu T; He F; Zhu TT; Li D; Zhang WF; Jiang JL; Hu CP
Pulm Pharmacol Ther; 2017 Jun; 44():70-77. PubMed ID: 28315789
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non‑coding RNA DLEU2 suppresses idiopathic pulmonary fibrosis by regulating the microRNA‑369‑3p/TRIM2 axis.
Yi H; Luo D; Xiao Y; Jiang D
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
